Coherus BioSciences, Inc. (CHRS)

Coherus BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	97.69	102.89	63.55	417.2	541.16	177.67
Short-Term Investments	-	14.86	128.13	-	-	-
Cash & Short-Term Investments	97.69	117.75	191.68	417.2	541.16	177.67
Cash Growth	-25.47%	-38.57%	-54.05%	-22.91%	204.59%	145.55%
Accounts Receivable	167.56	260.52	109.96	123.02	157.05	141.99
Receivables	198.8	260.52	109.96	123.02	157.05	141.99
Inventory	47.64	62.61	38.79	37.64	44.23	9.81
Prepaid Expenses	24.89	34.76	40.8	24.46	25.04	13.54
Total Current Assets	369.02	475.63	381.23	602.32	767.48	343.01
Property, Plant & Equipment	2.91	11.03	14.44	16.01	10.11	16.49
Goodwill	-	0.94	0.94	0.9	0.94	0.94
Other Intangible Assets	54.31	70.73	4.99	2.66	2.62	2.62
Other Long-Term Assets	78.75	71.27	79.24	57.44	60.5	45.87
Total Assets	505	629.6	480.85	679.33	841.65	408.93
Accounts Payable	21.89	35.22	11.53	16.16	15.2	25.99
Accrued Expenses	229.21	291.11	122.85	145.68	127.32	86.79
Current Portion of Leases	1.63	2.15	4.32	3.49	3.13	2.2
Other Current Liabilities	42.84	3.3	-	-	-	-
Total Current Liabilities	295.57	331.77	138.69	165.33	145.65	114.97
Long-Term Debt	264.51	473.37	471.06	408.28	404.02	178.39
Long-Term Leases	3.74	5.33	5.05	7.25	9.95	10.26
Long-Term Deferred Tax Liabilities	1.1	1.1	-	-	-	-
Other Long-Term Liabilities	28.06	11.46	3.47	0.75	1.05	0.1
Total Liabilities	592.97	823.03	618.27	581.61	560.68	303.71
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,413	1,386	1,204	1,148	1,044	1,001
Retained Earnings	-1,500	-1,580	-1,342	-1,050	-762.75	-895
Comprehensive Income & Other	-0.28	-0.25	-0.25	-0.27	-0.27	-0.56
Total Common Equity	-87.97	-193.43	-137.42	97.73	280.97	105.21
Shareholders' Equity	-87.97	-193.43	-137.42	97.73	280.97	105.21
Total Liabilities & Equity	505	629.6	480.85	679.33	841.65	408.93
Total Debt	269.88	480.84	480.42	419.02	417.1	190.84
Net Cash (Debt)	-172.19	-363.09	-288.74	-1.83	124.06	-13.17
Net Cash Per Share	-1.52	-3.86	-3.72	-0.02	1.49	-0.18
Filing Date Shares Outstanding	115.21	112.71	79.61	77.28	72.79	70.62
Total Common Shares Outstanding	115.21	112.22	78.85	76.93	72.51	70.37
Working Capital	73.46	143.86	242.54	437	621.83	228.04
Book Value Per Share	-0.76	-1.72	-1.74	1.27	3.87	1.50
Tangible Book Value	-142.29	-265.1	-143.35	94.16	277.41	101.65
Tangible Book Value Per Share	-1.23	-2.36	-1.82	1.22	3.83	1.44
Machinery	17.78	17.73	17.39	16.04	18.57	16.25
Construction In Progress	-	-	0.7	0.39	0.31	1.5
Leasehold Improvements	5.75	5.75	6.2	5.94	5.83	4.39

Source: S&P Capital IQ. Standard template. Financial Sources.